AMERICAN SHARED HOSPITAL SERVICES Revenue from Contract with Customer, Including Assessed Tax
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Revenue from Contract with Customer, Including Assessed Tax of $19.40 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-04-03.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2020-04-03
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, including assessed tax for fiscal 2019 was $19.40M, a 2.15% increase from fiscal 2018.
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, including assessed tax for fiscal 2018 was $18.99M.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|
| 2019-12-31 | $19.40M 10-K · filed 2020-04-03 |
| 2018-12-31 | $18.99M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |